<DOC>
	<DOCNO>NCT00003804</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . It yet know regimen chemotherapy effective stage I Wilms ' tumor . PURPOSE : Randomized phase III trial study effectiveness chemotherapy surgery treat child risk stage I Wilms ' tumor .</brief_summary>
	<brief_title>Chemotherapy Plus Surgery Treating Children Risk With Stage I Wilms ' Tumor</brief_title>
	<detailed_description>OBJECTIVES : I . Determine initial extension disease , surgical procedure , gross histological morphology , treatment , clinical outcome , late consequence therapy treatment neoadjuvant chemotherapy , surgery , adjuvant chemotherapy without maintenance chemotherapy patient intermediate risk anaplastic stage I Wilms ' tumor . II . Determine safety effectiveness reduce chemotherapy patient . OUTLINE : This randomize , multicenter study . Patients receive dactinomycin IV day 1-3 15-17 vincristine IV day 1 , 8 , 15 , 22 . Patients undergo surgery week completion chemotherapy . After surgery , patient receive vincristine IV day 1 , 8 , 15 , 22 dactinomycin IV day 8-12 . Patients randomize one two treatment arm week 9 . Arm I : Patients receive dactinomycin IV day 1-5 week 10 vincristine IV day 1 week 10 11 . This course repeat week 17 18 . Arm II : Patients receive treatment . Patients follow every 3 month 3 year , annually thereafter . Peer Reviewed Funded Endorsed Cancer Research UK PROJECTED ACCRUAL : A total 350 patient ( 175 per treatment arm ) accrue study within 7-8 year .</detailed_description>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Wilms Tumor</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Dactinomycin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Initial diagnosis unilateral tumor clinical radiological characteristic nephroblastoma Histologically proven stage I Wilms ' tumor neoadjuvant treatment surgery Intermediate risk anaplastic No detectable distant metastases 4 week adjuvant chemotherapy PATIENT CHARACTERISTICS : Age : 0.5 17 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>stage I Wilms tumor</keyword>
</DOC>